The Health Resources and Services Administration (HRSA) of the Department of Health and Human Services (HHS), in August announced more than $1.4 billion in Ryan White HIV/AIDS Program funding for the HRSA AIDS Drug Assistance Program (ADAP) and related awards. This HRSA funding ensures that individuals with HIV who have low incomes receive lifesaving medication, quality HIV health care and essential support services. This announcement supports and advances the Biden-Harris administration’s National HIV/AIDS Strategy.

 

HRSA-supported AIDS Drug Assistance Programs pay for HIV medication, co-pays and co-insurance for HIV medication and premiums for health insurance that covers HIV medication. This critical support helps individuals with HIV receive antiretroviral therapies, which help people reach viral suppression, meaning they cannot sexually transmit HIV and can live longer and healthier lives.

 

Without access to lifesaving HIV medication provided by HRSA-supported AIDS Drug Assistance Programs, HIV medication could cost an individual more than $40,000 per year, putting it otherwise out of reach. HRSA supports critical HIV care and medication
in all 50 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands and six U.S. Pacific territories.

 

HHS Deputy Secretary Andrea Palm announced the awards during the opening plenary session of HRSA’s 2024 National Ryan White Conference on HIV Care & Treatment in Washington, DC.

 

“The Ryan White HIV/AIDS Program is the cornerstone of this nation’s response to the HIV epidemic. Over half of people with diagnosed HIV in the United States—more than half a million people—receive services through the program each year,” said Palm. “This funding makes it possible for people with HIV to access lifesaving medication and treatment that are proven to improve health outcomes, reduce HIV transmission and save lives. We are incredibly proud of the department’s leadership of the federal effort to end the HIV epidemic in the United States and advance the Biden-Harris administration’s National HIV/AIDS Strategy.”